PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry ...

Economic realities: Pharma leadership is often conditioned for the "high-risk, high-reward" physics of pipeline assets. MedTech operates on iterative innovation and service-heavy models. Bridging ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

AI has been hailed as a way to speed up historically sluggish drug development, but an entirely AI-designed drug has yet to be approved by the FDA. The furthest along is likely Insilico Medicine’s ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

Qilu Pharmaceutical will oversee subsequent development and commercialisation activities.

Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space Stephen Ranjan learned how to be innovative while growing up ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...